《LANCET,3月19日, CORRESPONDENCE|ONLINE FIRST PDF [1 MB] Figures Save Share Reprints Request Prolonged presence of SARS-CoV-2 viral RNA in faecal samples》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-03-20
  • Prolonged presence of SARS-CoV-2 viral RNA in faecal samples

    Yongjian Wu,Cheng Guo,Lantian Tang,Zhongsi Hong,Jianhui Zhou,Xin Dong

    Published:March 19, 2020DOI:https://doi.org/10.1016/S2468-1253(20)30083-2

    We present severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) real-time RT-PCR results of all respiratory and faecal samples from patients with coronavirus disease 2019 (COVID-19) at the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China, throughout the course of their illness and obligated quarantine period. Real-time RT-PCR was used to detect COVID-19 following the recommended protocol (appendix p 1). Patients with suspected SARS-CoV-2 were confirmed after two sequential positive respiratory tract sample results. Respiratory and faecal samples were collected every 1–2 days (depending on the availability of faecal samples) until two sequential negative results were obtained. We reviewed patients' demographic information, underlying diseases, clinical indices, and treatments from their official medical records. The study was approved by the Medical Ethical Committee of The Fifth Affiliated Hospital of Sun Yat-sen University (approval number K162-1) and informed consent was obtained from participants. Notably, patients who met discharge criteria were allowed to stay in hospital for extended observation and health care.

  • 原文来源:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30083-2/fulltext
相关报告
  • 《CID,3月28日,Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-29
    • Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients Fengting Yu, Liting Yan, Nan Wang, Siyuan Yang, Linghang Wang, Yunxia Tang, Guiju Gao, Sa Wang, Chengjie Ma, Ruming Xie ... Show more Author Notes Clinical Infectious Diseases, ciaa345, https://doi.org/10.1093/cid/ciaa345 Published: 28 March 2020 Abstract Background Coronavirus disease 2019 (COVID-19) has become a public health emergency. The widely used reverse transcription PCR (RT-PCR) method has limitations for clinical diagnosis and treatment. Methods A total of 323 samples from 76 COVID-19 confirmed patients were analyzed by droplet digital PCR (ddPCR) and RT-PCR based two target genes (ORF1ab and N). Nasal swabs, throat swabs, sputum, blood, and urine were collected. Clinical and imaging data were obtained for clinical staging.
  • 《LANCET,3月20日,Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-04-01
    • Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward Christopher A Green, Mohammed N Quraishi, Sahida Shabir, Naveen Sharma, Richard Hansen, Daniel R Gaya, et al. Show all authors Published:March 30, 2020DOI:https://doi.org/10.1016/S2468-1253(20)30089-3 We thank Gianluca Ianiro and colleagues for highlighting an important concern faced by faecal microbiota transplant (FMT) stakeholders, including stool banks, regulators, and especially recipients, during the current coronavirus disease 2019 (COVID-19) pandemic. The authors are right in highlighting the concern arising from the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in stool samples and the safety implications for FMT donor screening policies. However, we strongly believe that the approach taken by the authors in excluding donors on the basis of having developed COVID-19 symptoms, having had contact with patients with confirmed COVID-19 disease, or having recently travelled to regions affected by COVID-19, is insufficient and potentially unsafe. The world is currently amid a global pandemic, exacerbated by a large burden of asymptomatic or mild cases; as of March 19, 2020, more than 80?000 known cases have been reported in Europe and the UK.